Nuplazid (pimavanserin capsules and tablets) — Cigna
Parkinson’s disease psychosis
Initial criteria
- Patient has hallucinations and delusions associated with Parkinson’s disease psychosis
- Patient does not have dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis
- Medication is prescribed by or in consultation with a neurologist
Approval duration
1 year